Table 4.
Baseline demographics and clinical characteristics grouped on the basis of types of HT.
| Characteristics | HI1 | HI2 | PH1 | PH2 | p |
|---|---|---|---|---|---|
| Demographics | |||||
| Age (years) | 65 (56.5, 76) | 73.5 (62.5, 79) | 69.5 (64, 82.5) | 73 (57, 86) | 0.256 |
| Sex, men, n (%) | 20 (36.4%) | 15 (27.3%) | 12 (21.8%) | 8 (14.5%) | 0.375 |
| Risk factors | |||||
| Smoking, n (%) | 11 (40.7%) | 7 (25.9%) | 6 (22.2%) | 3 (11.1%) | 0.812 |
| Drinking, n (%) | 5 (35.7%) | 3 (21.4%) | 2 (14.3%) | 4 (28.6%) | 0.206 |
| Hypertension, n (%) | 19 (30.6%) | 24 (38.7%) | 13 (21.0%) | 6 (9.7%) | 0.163 |
| Diabetes, n (%) | 5 (23.8%) | 9 (42.9%) | 5 (23.8%) | 2 (9.5%) | 0.397 |
| Stroke history, n (%) | 3 (20.0%) | 7 (46.7%) | 3 (20.0%) | 11 (11.2%) | 0.390 |
| Atrial fibrillation, n (%) | 16 (32.0%) | 17 (34.0%) | 10 (20.0%) | 7 (14.0%) | 0.615 |
| Coronary heart disease, n (%) | 16 (34.0%) | 18 (38.3%) | 9 (19.1%) | 4 (8.5%) | 0.608 |
| Clinical data | |||||
| Systolic BP (mmHg) | 140 (128.5, 162.5) | 142 (124.8, 163.0) | 149 (127.5, 181.3) | 160 (135, 178) | 0.517 |
| Diastolic BP (mmHg) | 82 (73.0, 96.5) | 78.5 (70.8, 92.3) | 83 (78.5, 95.3) | 90 (73.0, 103.0) | 0.593 |
| Admission NIHSS | 14 (10.0, 18.5) | 14 (11.3, 16.8) | 15 (10.8, 18.3) | 18 (14,23) | 0.176 |
| Time from onset to recanalization (minutes) | 390 (309.5, 611.5) | 404.5 (305.5, 609.8) | 352.5 (247.5, 459.5) | 413 (342.0, 760.0) | 0.610 |
| Time from arrival to recanalization (minutes) | 218 (175.0, 274.0) | 224.5 (163.8, 260.0) | 216.5 (183.8, 330.3) | 229 (173.0, 291.0) | 0.949 |
| ASPECTS | 7 (6,8) | 7 (6,8) | 7 (6, 7.3) | 6 (6,7) | 0.105 |
| Recanalization (mTICI ≥2b) (n%) | 12 (52.2%) | 6 (26.1%) | 5 (21.7%) | 0 (0.0%) | 0.119 |
| Occlusion site | |||||
| ICA | 9 (40.9%) | 9 (40.9%) | 3 (13.6%) | 1 (4.5%) | 0.390 |
| MCA | 16 (30.2%) | 19 (35.8%) | 10 (18.9%) | 8 (15.1%) | |
| Tandem occlusion | 12 (52.2%) | 4 (17.4%) | 5 (21.7%) | 11 (8.7%) | |
| Cause (TOAST) | |||||
| LAA (n%) | 19 (51.4%) | 10 (27.0%) | 5 (13.5%) | 3 (8.1%) | 0.253 |
| CE (n%) | 11 (33.3%) | 11 (33.3%) | 5 (15.2%) | 6 (18.2%) | |
| Other (n%) | 7 (25.0%) | 11 (39.3%) | 8 (28.6%) | 2 (7.1%) | |
| Laboratory data | |||||
| Blood glucose (mmol/L) | 6.4 (5.5, 7.9) | 7.5 (5.8, 9.3) | 9 (6.2, 11.1) | 6.5 (5.4, 9.0) | 0.078 |
| Platelet1, × 109/L | 193 (157.5, 222.5) | 176.5 (115.5, 197.3) | 197.5 (173.3, 233.8) | 216 (167, 225) | 0.079 |
| Monocytes1, × 109/L | 1.3 (0.8, 2.2) | 1.4 (0.6, 2.0) | 1.3 (0.7, 1.9) | 1.1 (0.7, 1.4) | 0.191 |
| Neutrophils1, × 109/L | 5.1 (2.7, 7.9) | 5.4 (2.9, 7.1) | 7.9 (3.7, 8.9) | 8.9 (6.1, 11.1) | 0.004 |
| Lymphocytes1, × 109/L | 1.3 (0.8, 2.2) | 1.4 (0.6, 2.0) | 1.3 (0.7, 1.9) | 1.1 (0.7, 1.4) | 0.664 |
| NLR1 | 139.1 (102.5, 200.9) | 141.4 (108.8, 218.8) | 199.2 (104.1, 250.7) | 161.3 (120.0, 341.7) | 0.063 |
| Platelet2, × 109/L | 182 (152.5, 240.0) | 166.5 (140.5, 205.8) | 194 (151, 213) | 199 (127, 218) | 0.566 |
| Monocytes2, × 109/L | 1.0 (0.9, 1.1) | 0.8 (0.6, 1.0) | 0.6 (0.6, 0.8) | 0.5 (0.3, 0.6) | 0.142 |
| Neutrophils2, × 109/L | 9.2 (8.0, 10.1) | 9.5 (8.0, 11.3) | 11.5 (9.3, 12.8) | 13.1 (9.8, 15.6) | 0.001 |
| Lymphocytes2, × 109/L | 1.0 (0.9, 1.1) | 0.8 (0.6, 1.0) | 0.6 (0.6, 0.8) | 0.5 (0.3, 0.6) | < .001 |
| NLR2 | 203.7 (159.5, 246.5) | 228.4 (150.1, 258.0) | 270.8 (236.7, 365.0) | 332.80 (254.0, 726.7) | < .001 |
HI, hemorrhagic infarction; PH, parenchymal hematoma; HI1, small patch hemorrhage at the edge of the infarction; HI2, fusion patch hemorrhage in the infarct area, no mass effect; PH1, hematoma < 30% of the infarct area; PH2, the hematoma exceeds 30% of the infarct area.